Dave Hause

With over three decades in formulation drug development, Dave Hause, an esteemed graduate of the University of North Carolina at Chapel Hill, embodies pharmaceutical innovation. His career showcases a knack for guiding projects from inception to commercial launch, especially in sustained-release multi-particulate dosage forms and immediate-release solid and lipid-based oral dosages. Dave excels in pre-formulation studies, formulation screening, stability protocols, and crafting test requirements. His dedication to pharmaceutical progress is highlighted by his contributions to pivotal patents, such as oral H2-Antagonists compositions and stabilized ramipril solutions. As the Director of Formulation Development at SmaBio Labs, Dave's profound expertise solidifies the company's standing at the pinnacle of innovation, safety, and pharmaceutical excellence.